Neisserial Heparin Binding Antigen (NHBA) is a surface-exposed lipoprotein and a component of 7 the Bexsero vaccine. NHBA is characterized by the presence of a highly conserved Arg-rich region 8 involved in binding to heparin and heparin sulphate proteoglycans present on the surface of host 9 epithelial cells, suggesting a possible role of NHBA during N. meningitidis colonization. NHBA has 10 been shown to be cleaved by the bacterial NalP protein, a meningococcal protease and by human 11 lactoferrin (hLF), a host protease present in different body fluids (saliva, breast milk and serum).
Purification of NHBA fragments after cleavage 167 NHBA recombinant protein was digested with saliva and recombinant KLK1 as previously 168 described and the obtained digested fragments were separated on His Spin Trap devices (GE 169 Healtcare) following the costumer procedure. The His Spin Trap was equilibrated with 50 mM 170 NaH 2 PO 4 pH8, 300 mM NaCl, NHBA cleaved recombinant protein was loaded on the devices and 171 after washing C-fragments waseluted with 50 mM NaH 2 PO 4 pH8, 300 mM NaCl, 500 mM 172 Imidazol. The C fragment recovered from His Spin Trap elution fractionwas analysed by Mass Spectrometry.
177
The acidified protein solutions were loaded onto a Protein Microtrap cartridge (from 60 to 100 178 pmols), desalted for 2 min with 0.1% (v/v) formic acid at a flow rate of 200 ml/min and eluted 179 directly into the mass spectrometer using a step gradient of acetonitrile (55% (v/v) acetonitrile, 180 0.1% (v/v) formic acid). Spectra were acquired in positive mode on a SynaptG2 HDMS mass spectrometer (Waters) equipped with a Z-spray ESI source. The quadrupole profile was optimized 182 to ensure the best transmission of all ions generated during the ionization process. Mass spectra 183 were smoothed, centroided and deconvoluted using MassLynx vers. 4.1 (Waters). Lactoferrin is not the main actor of NHBA cleavage in human saliva 232 To verify whether the protease responsible for NHBA cleavage in saliva was the hLF, proteins 233 contained in saliva were partially fractionated by Anion Exchange Chromatography. Proteins were 234 eluted by increasing ionic strength (Fig. S1 ), and each recovered fraction was examined for both the 235 ability to cleave NHBA protein and for the presence of hLf. The proteolytic activity of each fraction 236 on NHBA protein was monitored by SDS-PAGE analysis (Fig. 2B ), while the presence of hLf was 237 assessed by Western blot analysis ( Fig. 2A) . Surprisingly, while the hLF was mainly detected in 238 fractionsfrom 33 to 37, from 48 to 50 and 59 and 60, the majority of the proteolytic cleavage of 239 NHBA was observed from fraction 50 to fraction 56, suggesting that hLF was not the main factor, proteins, we found the protease kallikrein 1 (hKLK1), whose identity was assigned by the MS/MS 275 sequence of two peptides (Fig. 4 ). This isoform of kallikrein is specifically expressed in human To identify the exact cleavage site within the NHBA protein promoted by hKLK1 and saliva, we 308 purified the C-terminal fragments generated by their cleavage. Therefore, NHBA was incubated 309 with saliva or with rhKLK1 (recombinant human kallikrein 1) overnight and the resulting fragments 310 were separated by affinity chromatography. Since NHBA was His-tagged at the C-terminus, we 311 used NiNtA resin to bind and purify the cleaved C-terminal fragments, while N-terminal fragments 312 were not bound to the column and released in the flow through (Fig. 2S) .
313
Once the cleaved C-term fragments generated by human saliva and recombinant human kallikrein1 314 were purified, they were analyzed by mass spectrometry to determine their precise molecular (Fig. 6A) . Similarly, the NHBA fragment derived 320 from recombinant human kallikrein1 cleavage showed a molecular weight of 20247.3 Da ± 2 Da 321 ( Fig. 6B ) that was also compatible with the same C-terminal sequence starting from Ser 288 . We 322 therefore concluded that the cleavage site of both hKLK1 and saliva was located immediately Since in-vitro data proved that hKLK1 was the main protease in saliva responsible for the 339 proteolytic cleavage of NHBA into two main fragments, the N-and C-terminal , we further verified 340 their ability to process NHBA on native protein expressed on the surface of live bacteria.
341
To test NHBA processing on live bacteria, Neisseria meningitidis MC58 wild-type strain and the 342 relative knock-outs for nalP gene ( coding for the meningococcal serine protease able to cleave 343 NHBA) and NHBA gene, as a control strains, were grown at 32°C to simulate the nasopharyngeal 344 environment [14], and then treated with hKLK1 or saliva. After 30 minutes, samples were collected 345 and the presence of the NHBA C-terminal domain was assessed either into supernatants by Western 346 blot analysis (Fig. 7A ) or on bacterial surface by FACS analysis (Fig. 7B ). As previously reported 347 [7], the NHBA-C terminal fragment derived for cleavage of meningococcal NalP protease, named 348 C2, could be detected in supernatant of MC58 wt (Fig. 7A, lane 4) . In addition, a shorter NHBA C- whether the proteolytic cleavage of NHBA could happen in saliva, being the nasopharynx the only 402 known N. meningitidis bacterial reservoir, and the first tissue where the bacterium starts its 403 colonization. Understanding the mechanism which allows the bacterium to pass through the human 404 nasopharyngeal epithelium and start its invasive phase is a crucial step to develop a preventive 405 treatment for meningitis disease. For this purpose, we evaluated the possibility that NHBA could be 406 processed by human saliva, the main fluid present in the nasopharyngeal tract. In this work, we 407 demonstrate that NHBA is cleaved in vitro by human saliva into two main fragments, an N-terminal 408 fragment (AB) and a C-terminal fragment (C1), and that C1 is the same fragment generated by hLf 409 processing of NHBA; we found, however, that the main actor for NHBA processing in saliva is not . 415 We have so far three proteases able to cleave NHBA in vitro, upstream or downstream the Arg-rich . 420 To further characterize and understand the possible biological relevance of NHBA processing we 421 compared the activity of human saliva with the newly identified NHBA cleaving protease, hKLK1, 422 on the bacterial surface by testing their ability to process NHBA on live bacteria. We showed that 423 NHBA is processed in ΔNalP MC58 strain by saliva and by hKLK1 generating an identical peptide 424 with a MW equal to the C1 fragmen,t and it is also processed by NalP, generating the C2 fragment.
425
Both fragments, C1 and C2 are released in the culture medium. 426 We demonstrated that NHBA can be cleaved on live bacteria releasing two main fragments, C1 and 427 C2, from the bacterial surface. Hence, we speculated whether the two different C-term fragments 
432
It was also shown that C2, but not C1, increases endothelial permeability with a mechanism 433 involving the production of oxygen radicals and the phosphorylation and degradation of adherents-434 junction protein VE-cadherin.
[15]. Since the C2 fragment contains the Arg-rich domain it is 435 plausible that this fragment might interact with secreted or cell-associated proteoglycans in order to 436 exert its biological role [15]. Moreover, the C2 fragment seems to be critical for invasion of human 437 tissues, hence for virulence, and different studies showed the possibility that it is naturally released 438 in the bacterial environment. We can also assume that the C1 fragment, released by N. meningitidis 439 in the nasopharyngeal tract in its first colonization phase and processed in vivo by KLK1 present in 440 saliva and therefore lacking the Arginine-rich domain responsible for binding to heparin, is not able 441 to adhere on endothelial cell proteoglycans and enter the blood stream [15]. Therefore, hKLK1, and possibly to a lesser extent hLf, producing an inactive C-fragment, may have a protective role for the 443 host.
444
The Arg-rich region is highly conserved among different NHBA proteins and across MenB strains 445 [7], suggesting a crucial role in NHBA function in its ability to bind heparin. However, there is yet 446 no concrete explanation why, in the pharyngeal tract, three proteases are involved in NHBA 447 processing, with meningococcal NalP targeting the Arg-rich region upstream, and human KLK1 448 and human lactoferrin targeting it and downstream. Also it is not clear why a domain which is the 449 target of the front-line host defense mechanism is so widely conserved among Neisseria subtypes. This aspect opens the possibility that NHBA processing by host proteases would not be solely a 461 host defense mechanism, but could be crucial for the bacterium decision-making process in the 462 carriage-to-virulence switch, hence its conservation among N. meningitidis subtypes.
463
Further studies may consider investigating the environmental conditions which activate or inhibit 464 NalP or KLK1 functions, and how these could affect meningococcus virulence and invasiveness. 
